[go: up one dir, main page]

SE0004053D0 - N-type calcium channel antagonists for the treatment of pain - Google Patents

N-type calcium channel antagonists for the treatment of pain

Info

Publication number
SE0004053D0
SE0004053D0 SE0004053A SE0004053A SE0004053D0 SE 0004053 D0 SE0004053 D0 SE 0004053D0 SE 0004053 A SE0004053 A SE 0004053A SE 0004053 A SE0004053 A SE 0004053A SE 0004053 D0 SE0004053 D0 SE 0004053D0
Authority
SE
Sweden
Prior art keywords
treatment
pain
calcium channel
type calcium
channel antagonists
Prior art date
Application number
SE0004053A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0004053A priority Critical patent/SE0004053D0/sv
Publication of SE0004053D0 publication Critical patent/SE0004053D0/sv
Priority to AU2002212894A priority patent/AU2002212894A1/en
Priority to AT01981239T priority patent/ATE323693T1/de
Priority to DE60118956T priority patent/DE60118956T2/de
Priority to EP01981239A priority patent/EP1339706B1/en
Priority to US10/415,785 priority patent/US6815447B2/en
Priority to PCT/SE2001/002388 priority patent/WO2002036586A1/en
Priority to JP2002539345A priority patent/JP2004513125A/ja
Priority to ES01981239T priority patent/ES2261496T3/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE0004053A 2000-11-06 2000-11-06 N-type calcium channel antagonists for the treatment of pain SE0004053D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE0004053A SE0004053D0 (sv) 2000-11-06 2000-11-06 N-type calcium channel antagonists for the treatment of pain
AU2002212894A AU2002212894A1 (en) 2000-11-06 2001-10-31 N-type calcium channel antagonists for the treatment of pain
AT01981239T ATE323693T1 (de) 2000-11-06 2001-10-31 Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
DE60118956T DE60118956T2 (de) 2000-11-06 2001-10-31 Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
EP01981239A EP1339706B1 (en) 2000-11-06 2001-10-31 N-type calcium channel antagonists for the treatment of pain
US10/415,785 US6815447B2 (en) 2000-11-06 2001-10-31 N-type calcium channel antagonists for the treatment of pain
PCT/SE2001/002388 WO2002036586A1 (en) 2000-11-06 2001-10-31 N-type calcium channel antagonists for the treatment of pain
JP2002539345A JP2004513125A (ja) 2000-11-06 2001-10-31 疼痛治療のためのｎ−型カルシウムチャンネル拮抗薬
ES01981239T ES2261496T3 (es) 2000-11-06 2001-10-31 Antagonistas de los canales de calcio de tipo n para el tratamiento del dolor.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0004053A SE0004053D0 (sv) 2000-11-06 2000-11-06 N-type calcium channel antagonists for the treatment of pain

Publications (1)

Publication Number Publication Date
SE0004053D0 true SE0004053D0 (sv) 2000-11-06

Family

ID=20281713

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0004053A SE0004053D0 (sv) 2000-11-06 2000-11-06 N-type calcium channel antagonists for the treatment of pain

Country Status (9)

Country Link
US (1) US6815447B2 (sv)
EP (1) EP1339706B1 (sv)
JP (1) JP2004513125A (sv)
AT (1) ATE323693T1 (sv)
AU (1) AU2002212894A1 (sv)
DE (1) DE60118956T2 (sv)
ES (1) ES2261496T3 (sv)
SE (1) SE0004053D0 (sv)
WO (1) WO2002036586A1 (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040259866A1 (en) * 1998-06-30 2004-12-23 Snutch Terrance P. Calcium channel blockers comprising two benzhydril moieties
MXPA04011472A (es) * 2002-05-22 2005-02-14 Amgen Inc Derivados de amino-piridina, piridina y piridazina para usarse como ligandos del receptor vaniloide para el tratamiento del dolor.
WO2004014871A1 (en) 2002-08-08 2004-02-19 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US7419984B2 (en) * 2002-10-17 2008-09-02 Cell Therapeutics, Inc. Pyrimidines and uses thereof
MXPA05005477A (es) 2002-11-21 2005-07-25 Chiron Corp Pirimidinas 2,4,6-trisustituidas como inhibidores de fosfotidilinositol (pi) 3-cinasa y su uso en el tratamiento del cancer.
WO2005051392A1 (en) * 2003-11-20 2005-06-09 Children's Hospital Medical Center Gtpase inhibitors and methods of use
WO2006089311A1 (en) 2005-02-15 2006-08-24 Amgen Inc. Vanilloid receptor ligands and their use in treatments
CA2603926A1 (en) * 2005-04-08 2006-10-12 Neuromed Pharmaceuticals Ltd. Combination therapy comprising an n-type calcium channel blocker for the alleviation of pain
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
CA2651811A1 (en) * 2006-05-11 2007-11-22 Neuromed Pharmaceuticals Ltd. Method for increasing the bioavailability of benzhydryl piperazine containing compounds
CA2675558A1 (en) 2007-02-06 2008-08-14 Novartis Ag Pi 3-kinase inhibitors and methods of their use
WO2011109254A1 (en) 2010-03-04 2011-09-09 Merck Sharp & Dohme Corp. Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders
US9309199B2 (en) 2010-03-04 2016-04-12 Merck Sharp & Dohme Corp. Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
WO2011109267A1 (en) * 2010-03-04 2011-09-09 Merck Sharp & Dohme Corp. Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders
US8409560B2 (en) 2011-03-08 2013-04-02 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof
AU2012225459A1 (en) 2011-03-08 2013-10-10 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof
WO2013046136A1 (en) 2011-09-27 2013-04-04 Novartis Ag 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
UY34632A (es) 2012-02-24 2013-05-31 Novartis Ag Compuestos de oxazolidin- 2- ona y usos de los mismos
US9296733B2 (en) 2012-11-12 2016-03-29 Novartis Ag Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases
EA028033B1 (ru) 2013-03-14 2017-09-29 Новартис Аг 3-пиримидин-4-ил-оксазолидин-2-оны в качестве ингибиторов мутантного idh

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB794043A (en) 1955-06-03 1958-04-30 Ici Ltd New quinoline derivatives
CA2325638A1 (en) * 1998-03-26 1999-09-30 Hideki Yamada Amide derivatives and nociceptin antagonists

Also Published As

Publication number Publication date
DE60118956D1 (de) 2006-05-24
ATE323693T1 (de) 2006-05-15
US20040058945A1 (en) 2004-03-25
JP2004513125A (ja) 2004-04-30
EP1339706A1 (en) 2003-09-03
WO2002036586A1 (en) 2002-05-10
EP1339706B1 (en) 2006-04-19
ES2261496T3 (es) 2006-11-16
DE60118956T2 (de) 2007-03-15
US6815447B2 (en) 2004-11-09
AU2002212894A1 (en) 2002-05-15

Similar Documents

Publication Publication Date Title
SE0004053D0 (sv) N-type calcium channel antagonists for the treatment of pain
SE0102858D0 (sv) N-type calcium channel antagonists for the treatment of pain
IS6658A (is) Ný efnasambönd
MY115662A (en) Novel compounds with analgesic effect
ATE312843T1 (de) Neues cyclosporin mit verbesserter wirkung
PT1411908E (pt) Tratamento de infeccoes da unha com no
DE60334379D1 (de) Copolymerverbindung, diese enthaltende polymerzusammensetzung, bilderzeugungsverfahren und dieselbe benutzende bilderzeugungsvorrichtung
ES2191208T3 (es) Oxiimino-pregnano-carbolactonas.
CY1108808T1 (el) Ενωσεις μοτιλιδης
SE0004054D0 (sv) N-type calcium channel antagonists for the treatment of pain
SE0302139D0 (sv) Novel compounds
SE9802208D0 (sv) Novel compounds
MY133969A (en) Indoloquinazolinones
EP1423137A4 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
TR200002896T2 (tr) Kalsilitik Bileşimler
ES2221950T3 (es) Dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios.
SE0003476D0 (sv) Compounds
SE0203070D0 (en) Novel compounds
SE0303280D0 (sv) Novel compounds
SE9802209D0 (sv) Novel compounds
PT1204659E (pt) Benzofuranos serotoninergicos
SE9504662D0 (sv) New compounds
SE0004056D0 (sv) N-type calcium channel antagonists for the treatment of pain
SE0004055D0 (sv) N-type calcium channel antagonists for the treatment of pain
YU35303A (sh) Preparati n-(1-metiletilaminokarbonil)-4-(3-metilfenil-amino)-3-piridinsulfonamida i cikličnih oligosaharida